Arden was diagnosed with stage IV, high-risk neuroblastoma at 9 months old. She spent 9 months working hard to fight this rare form of cancer, but after an aggressive relapse, Arden lost her battle in February 2014 when she was almost 18 months old.

But Arden’s fight didn’t end that day.

Arden would have wanted us to keep fighting—to pick up where she left off and help create better options for the children who come after her. Your support directly fuels neuroblastoma research and clinical trials across the country, helping researchers discover the breakthroughs that can one day lead to a cure.

There are still no reliably effective, established treatments for relapsed neuroblastoma patients like Arden. That is why research matters. That is why clinical trials matter. And that is why your support matters.

Together, we can help researchers develop safer and more effective treatments for neuroblastoma—and give children facing this devastating disease something Arden didn’t have: more hope and more options. Help us continue Arden’s fight and work toward a day when no child or family has to endure what ours did.